SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000018
Filing Date
2024-06-20
Accepted
2024-06-20 20:30:51
Documents
3
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718929843.html 4  
1 FORM 4 wk-form4_1718929843.xml 4 9584
2 EX-24 poasection16filings-gugg.htm EX-24 4122
3 poasection16filings-gugg001.jpg GRAPHIC 249470
  Complete submission text file 0001649094-24-000018.txt   358972
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241058153

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)